APA

Lunniss C. J., Cooper A. W. J., Eldred C. D., Kranz M., Lindvall M., Lucas F. S., Neu M., Preston A. G. S., Ranshaw L. E., Redgrave A. J., Ed Robinson J., Shipley T. J., Solanke Y. E., Somers D. O. & Wiseman J. O. (20090828). Quinolines as a novel structural class of potent and selective PDE4 inhibitors: optimisation for oral administration. : Bioorganic & medicinal chemistry letters.

Chicago

Lunniss Christopher J, Cooper Anthony W J, Eldred Colin D, Kranz Michael, Lindvall Mika, Lucas Fiona S, Neu Margarete, Preston Alex G S, Ranshaw Lisa E, Redgrave Alison J, Ed Robinson J, Shipley Tracy J, Solanke Yemisi E, Somers Don O and Wiseman Joanne O. 20090828. Quinolines as a novel structural class of potent and selective PDE4 inhibitors: optimisation for oral administration. : Bioorganic & medicinal chemistry letters.

Harvard

Lunniss C. J., Cooper A. W. J., Eldred C. D., Kranz M., Lindvall M., Lucas F. S., Neu M., Preston A. G. S., Ranshaw L. E., Redgrave A. J., Ed Robinson J., Shipley T. J., Solanke Y. E., Somers D. O. and Wiseman J. O. (20090828). Quinolines as a novel structural class of potent and selective PDE4 inhibitors: optimisation for oral administration. : Bioorganic & medicinal chemistry letters.

MLA

Lunniss Christopher J, Cooper Anthony W J, Eldred Colin D, Kranz Michael, Lindvall Mika, Lucas Fiona S, Neu Margarete, Preston Alex G S, Ranshaw Lisa E, Redgrave Alison J, Ed Robinson J, Shipley Tracy J, Solanke Yemisi E, Somers Don O and Wiseman Joanne O. Quinolines as a novel structural class of potent and selective PDE4 inhibitors: optimisation for oral administration. : Bioorganic & medicinal chemistry letters. 20090828.